13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 22:01:48 UTC, with 18 holding rows worth $488,204,016.
- Accession
- 0001791827-26-000008
- Filer
- CIK 1791827
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
13F report for Q3 2026
A holdings report, 18 entries on the cover page, a total value of $488,204,016 stated on the cover page (in dollars after the unit check, H1), rows summing to $488,204,016 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 1,899,593 | $167,259,164 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,348,948 | $95,626,924 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 785,424 | $65,417,965 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 850,000 | $60,256,500 | dollars as filed | call |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 2,000,000 | $28,100,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 550,000 | $25,212,000 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 6,067,999 | $16,686,997 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 484,200 | $9,427,374 | dollars as filed | |
| IMMUNIC INC | 4525EP200 | COM NEW | 669,941 | $6,230,451 | dollars as filed | |
| MOBIA MED INC | 60705V103 | COMMON STOCK | 324,676 | $3,068,188 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 20,000 | $2,758,600 | dollars as filed | |
| NUVECTIS PHARMA INC | 67080T108 | COMMON STOCK | 100,415 | $2,120,765 | dollars as filed | |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 164,019 | $1,394,162 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 4,060,254 | $1,219,700 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 884,900 | $1,079,578 | dollars as filed | |
| SENSEONICS HOLDINGS INC | 81727U303 | COMMON STOCK | 100,000 | $1,017,000 | dollars as filed | |
| SCYNEXIS INC | 811292309 | COM | 153,613 | $758,848 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 20,000 | $569,800 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-26-000008 | this filing | 2026-11-16 |